2
Feb 2026
The loss of social connectedness as people age increases the odds of cognitive-related disorders and can worsen health outcomes in older populations. But is there a direct relationship between social behavior and cognition? Subhadeep Dutta Gupta, Peter Rapp, and colleagues, from the National Institute on Aging, developed a rat model to probe social cognition in the aging brain.
2
Feb 2026
Climate worry is associated with depressive and anxiety symptoms among Finns of all ages. However, these symptoms are less common among individuals whose climate-related hope is combined with various forms of action, such as volunteering, following a plant‑based diet or avoiding air travel.
2
Feb 2026
New study shows how bacteria adapted a virus-derived injection system to recognize and attach to many different types of cells.
2
Feb 2026
Physical aggression by young people toward their parents occurs quite frequently – yet the subject remains taboo.
2
Feb 2026
The first study to test a digital tool designed to help people with Long COVID manage their energy levels has been developed by a team of researchers.
2
Feb 2026
The majority (57.5 percent) of commercially insured patients had at least one chronic condition in 2024. The average allowed amount for a patient with no chronic conditions was $1,590, while the average allowed amount for a patient with one chronic condition was nearly double ($3,039).
2
Feb 2026
Researchers at the Johns Hopkins Kimmel Cancer Center have developed a novel liquid biopsy approach to identify early-stage cancers by measuring the random variation in DNA methylation patterns, rather than the absolute level of those patterns as in other liquid biopsies.
2
Feb 2026
The familiar labels "night owl" and "early bird," long used in sleep research, don't fully capture the diversity of human internal clocks, a new study has found.
2
Feb 2026
As we age, we begin to lose the connections that wire up our brains-and neuroscientists aren't sure why.
2
Feb 2026
Natalie McCormick, PhD, of the Rheumatology and Allergy Clinical Epidemiology Research (RACER) Center within the Division of Rheumatology in the Mass General Brigham Department of Medicine, is the lead author of a paper published in Diabetes Care, "Gout-Related Medication Use After Initiating Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Gout and Type 2 Diabetes: Population-Based Target Trial Emulation Studies."
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
